Dosimetric evaluation of a newly designed low dose rate brachytherapy applicator for treatment of cervical cancer with extension into the lower vagina

Journal of Applied Clinical Medical Physics

Volumn 8, Issue 2, 2007, Pages 37-46

  Baker, Curtis ^a   Dini, Sharifeh A ^a   Kudrimoti, Mahesh ^a   Awan, Shahid B ^a   Meigooni, Ali S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cervical cancer; Dosimetry; Meigooni applicator; Vaginal

Indexed keywords

EID: 34249944061     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v8i2.2400     Document Type: Article

References (11)

1. Brenner DJ, Hall EJ. Fractionated high dose rate versus low dose rate regimens for intracavitary brachytherapy of the cervix. I. General considerations based on radiobiology. Br J Radiol. 1991;64(758):133-141.
2. Dale RG, Jones B. The clinical radiobiology of brachytherapy. Br J Radiol. 1998;71(845):465-483.
3. Hareyama M, Sakata K, Oouchi A, et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial. Cancer. 2002;94(1):117-124.
4. Fields AL, Jones JG, Thomas GM, Runowicz CD. Gynecologic cancer [Chapter 19]. In: Lenhard RE Jr, Osteen RT, Gansler T, editors. Clinical oncology. Atlanta (GA): American Cancer Society; 2001: 455-496.
5. Cheng JCH, Peng L, Chen YH, Huang DYC, Wu JK, Jan JJM. Unique role of proximal rectal dose in late rectal cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2003;57(4): 1010-1018.
6. Ferrigno R, Nishimoto IN, Novaes PE, et al. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series. Int J Radiat Oncol Biol Phys. 2005;62(4):1108-1116.
7. Potish RA, Gerbi BJ. Cervical cancer: intracavitary dose specification and prescription. Radiology. 1987;165(2):555-560.
8. Meigooni AS, Mishra V, Panth H, Williamson J. Instrumentation and dosimeter-size artifacts in quantitative thermoluminescent dosimetry of low dose fields. Med Phys. 1995;22(5):555-561.
9. 125I brachytherapy source. Med Phys. 2000;27(9):2168-2173.
10. Casal E, Ballester F, Lluch JL, Perez-Calatayud J, Lliso F. Monte Carlo calculations of dose rate distributions around the Amersham CDCS-M-type Cs source. Med Phys. 2000;27(1):132-140.
11. Meisberger LL, Keller RJ, Shalek RJ. The effective attenuation of water of the gamma rays of gold 198, iridium 192, cesium 137, radium 226, and cobalt 60. Radiology. 1968;90(5):953-957.